Exercise tests in Chagas cardiomyopathy: an overview of functional evaluation, prognostic significance, and current challenges.


Journal

Revista da Sociedade Brasileira de Medicina Tropical
ISSN: 1678-9849
Titre abrégé: Rev Soc Bras Med Trop
Pays: Brazil
ID NLM: 7507456

Informations de publication

Date de publication:
2020
Historique:
received: 09 03 2020
accepted: 21 05 2020
entrez: 9 7 2020
pubmed: 9 7 2020
medline: 24 7 2020
Statut: ppublish

Résumé

Patients with Chagas cardiomyopathy (ChC) usually progress with fatigue and dyspnea. Exercise tests are valuable for the functional evaluation of these patients. However, information about the applicability of the exercise tests is scattered, and no studies have systematically reviewed the results. Thus, the present review explored the general aspects and prognostic value of exercise tests in patients with ChC. A literature search of the MEDLINE, Web of Science, CINAHL, Scopus, and LILACS databases was performed to identify relevant studies. There were no data restrictions, and articles that met the objective of the study were selected. Articles written in English, Portuguese, and Spanish were considered, and 25 articles were finally included. The peak oxygen uptake (VO2peak) was correlated with demographic and echocardiographic variables. Echocardiographic features of the left ventricular diastolic function and right ventricular systolic function appeared to be determinants of functional capacity, in addition to age and sex. VO2peak was associated with higher mortality, especially in patients with dilated ChC. The minute ventilation/carbon dioxide production slope (VE/VCO2 slope) was a strong predictor of survival; however, more studies are needed to verify this observation. Field tests showed moderate to strong correlation with VO2peak and thus may be inexpensive tools for the functional evaluation of patients with ChC. However, few studies have verified their prognostic significance. While exercise tests are useful tools for functional assessment, information is scarce regarding further considerations, and many of the criteria are based on guidelines for other heart diseases.

Identifiants

pubmed: 32638887
pii: S0037-86822020000100204
doi: 10.1590/0037-8682-0100-2020
pmc: PMC7341832
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e20200100

Références

Echocardiography. 2010 May;27(5):519-24
pubmed: 20412275
Rev Soc Bras Med Trop. 2005 Sep-Oct;38(5):373-6
pubmed: 16172749
J Am Coll Cardiol. 2017 Sep 26;70(13):1618-1636
pubmed: 28935040
Int J Parasitol. 2019 Mar;49(3-4):301-310
pubmed: 30738925
Int J Cardiol. 2000 Nov-Dec;76(2-3):101-5
pubmed: 11104861
Circulation. 1994 Dec;90(6):3098-102
pubmed: 7994859
Biomed Res Int. 2013;2013:849504
pubmed: 24350293
Qual Life Res. 2019 Jan;28(1):67-72
pubmed: 30167935
Int J Cardiol. 2008 Mar 28;125(1):139-41
pubmed: 17399822
Am Heart J. 2010 Dec;160(6):1004-14
pubmed: 21146651
Int J Prev Med. 2014 Feb;5(2):152-8
pubmed: 24627740
Rev Soc Bras Med Trop. 1997 Mar-Apr;30(2):129-38
pubmed: 9148336
Arq Bras Cardiol. 2017 Mar;108(3):246-254
pubmed: 28443956
Physiother Res Int. 2014 Mar;19(1):8-15
pubmed: 23703777
Circulation. 2007 Jul 17;116(3):329-43
pubmed: 17576872
Rev Port Cardiol. 2017 Dec;36(12):927-934
pubmed: 29223851
Rev Soc Bras Med Trop. 2003 Sep-Oct;36(5):545-50
pubmed: 14576866
Rev Soc Bras Med Trop. 2004 Sep-Oct;37(5):376-83
pubmed: 15361953
Int J Cardiol. 2017 Feb 1;228:385-387
pubmed: 27866032
Rev Soc Bras Med Trop. 2007 May-Jun;40(3):311-5
pubmed: 17653467
Br Heart J. 1995 Sep;74(3):293-5
pubmed: 7547025
Rev Soc Bras Med Trop. 2018 Jul-Aug;51(4):413-414
pubmed: 30133621
Trop Med Int Health. 2017 Oct;22(10):1314-1321
pubmed: 28805026
Cardiovasc Res. 2003 Oct 15;60(1):96-107
pubmed: 14522411
Int J Cardiol. 2008 Sep 16;129(1):86-92
pubmed: 17707926
Open Cardiovasc Med J. 2010 May 26;4:127-34
pubmed: 20657715
Thorax. 1992 Dec;47(12):1019-24
pubmed: 1494764
Eur J Echocardiogr. 2010 Aug;11(7):590-5
pubmed: 20304840
Circulation. 2010 Jul 13;122(2):191-225
pubmed: 20585013
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
pubmed: 12091180
J Exerc Rehabil. 2018 Oct 31;14(5):844-850
pubmed: 30443532
J Card Fail. 2000 Sep;6(3):220-4
pubmed: 10997748
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
Arq Bras Cardiol. 2011 Jun;96(6):434-42
pubmed: 21789345
Mem Inst Oswaldo Cruz. 2018 Aug 20;113(10):e180224
pubmed: 30133549
J Am Coll Cardiol. 1995 Apr;25(5):1143-53
pubmed: 7897128
Wkly Epidemiol Rec. 2015 Feb 6;90(6):33-43
pubmed: 25671846
Rev Soc Bras Med Trop. 2009 Nov-Dec;42(6):622-8
pubmed: 20209343
Rev Soc Bras Med Trop. 2018 Jul-Aug;51(4):421-426
pubmed: 30133623
Int J Cardiol. 2014 Dec 15;177(2):661-3
pubmed: 25449475
Nat Rev Cardiol. 2012 Oct;9(10):576-89
pubmed: 22847166
JAMA. 2009 Jan 21;301(3):286-94
pubmed: 19155455
Parasit Vectors. 2018 Jun 19;11(1):354
pubmed: 29914550
Rev Soc Bras Med Trop. 2016 Dec;49Suppl 1(Suppl 1):3-60
pubmed: 27982292
Eur J Phys Rehabil Med. 2016 Feb;52(1):20-7
pubmed: 26530211
Rev Soc Bras Med Trop. 1998 May-Jun;31(3):301-14
pubmed: 9612022
Am Heart J. 2006 Aug;152(2):297.e1-7
pubmed: 16875912
Rev Soc Bras Med Trop. 2010 Jul-Aug;43(4):405-8
pubmed: 20802940
Ther Adv Cardiovasc Dis. 2019 Jan-Dec;13:1753944719870084
pubmed: 31441375
Int J Cardiol. 2013 Oct 9;168(4):4584-5
pubmed: 23871619
Circulation. 1982 Jun;65(6):1213-23
pubmed: 6804111
Arq Bras Cardiol. 1986 Sep;47(3):201-5
pubmed: 3109355
Circulation. 2018 Sep 18;138(12):e169-e209
pubmed: 30354432
Pacing Clin Electrophysiol. 2011 Nov;34(11):1492-7
pubmed: 21797898
Circ Heart Fail. 2012 Sep 1;5(5):579-85
pubmed: 22773109
Am Heart J. 2004 Feb;147(2):354-60
pubmed: 14760336
Expert Rev Anti Infect Ther. 2007 Aug;5(4):727-43
pubmed: 17678433
Rev Soc Bras Med Trop. 2015 Mar-Apr;48(2):175-80
pubmed: 25992932

Auteurs

Henrique Silveira Costa (HS)

Departamento de Fisioterapia, Faculdade de Ciências Biológicas e da Saúde, Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, MG, Brasil.

Márcia Maria Oliveira Lima (MMO)

Departamento de Fisioterapia, Faculdade de Ciências Biológicas e da Saúde, Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, MG, Brasil.

Pedro Henrique Scheidt Figueiredo (PHS)

Departamento de Fisioterapia, Faculdade de Ciências Biológicas e da Saúde, Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, MG, Brasil.

Vanessa Pereira Lima (VP)

Departamento de Fisioterapia, Faculdade de Ciências Biológicas e da Saúde, Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, MG, Brasil.

Matheus Ribeiro Ávila (MR)

Departamento de Fisioterapia, Faculdade de Ciências Biológicas e da Saúde, Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, MG, Brasil.

Kenia Kiefer Parreiras de Menezes (KKP)

Curso de pós-graduação em Ciências da Reabilitação, Escola de Educação Física, Fisioterapia e Terapia Ocupacional, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brasil.

Vanessa Amaral Mendonça (VA)

Departamento de Fisioterapia, Faculdade de Ciências Biológicas e da Saúde, Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, MG, Brasil.

Ana Cristina Rodrigues Lacerda (ACR)

Departamento de Fisioterapia, Faculdade de Ciências Biológicas e da Saúde, Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, MG, Brasil.

Maria Carmo Pereira Nunes (MCP)

Curso de pós-graduação em Infectologia e Medicina Tropical, Escola de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brasil.

Mauro Felippe Felix Mediano (MFF)

Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brasil.

Manoel Otávio da Costa Rocha (MODC)

Curso de pós-graduação em Infectologia e Medicina Tropical, Escola de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brasil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH